查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591972

影像导引治疗系统市场：按产品、矫正策略、应用和最终用户 - 2025-2030 年全球预测

Image-guided Therapy System Market by Product (Computed Tomography Imaging, Intervention X-ray, Magnetic Resonance Imaging), Correction Strategy (Offline, On Line), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年影像导引治疗系统市值为44.6亿美元，预计2024年将达到47.9亿美元，复合年增长率为7.27%，到2030年将达到73亿美元。

影像导引治疗系统 (IGTS) 是影像和治疗技术的复杂结合，可为手术和治疗过程提供精确的介入。这些系统在手术过程中提供即时影像资料，对于实现微创手术、改善患者治疗效果以及缩短恢復时间至关重要。这项需求源自于神经病学、心臟病学、整形外科和肿瘤学等各个医学领域对准确、有效和微创治疗的需求不断增长。最终用途正在扩展到寻求提高手术能力的医院、诊所和研究机构。慢性病盛行率上升、人口老化寻求侵入性较小的医疗程序以及 MRI、 电脑断层扫描和超音波等诊断成像方式的持续技术进步推动了市场的发展。此外，人工智慧和机器学习应用正在释放提高资料准确性和治疗效率的潜在机会。关键的成长要素还包括对医疗基础设施的投资增加、政府对先进治疗技术的激励以及精准医学研发的增加。然而，市场面临设备高成本、需要专业技能的程序复杂以及严格的法规环境等限制。持续的挑战包括网路安全风险和与数位整合系统相关的互通性问题。创新机会存在于开发具有成本效益的可携式IGTS 解决方案以及整合先进的人工智慧主导分析以获取预测见解。此外，即时 3D影像处理和扩增实境(AR) 的突破性进展可能会进一步彻底改变手术辅助。企业可以透过投资与高科技公司的合作伙伴关係、加强其研发能力并专注于对先进医疗技术需求不断增长的新兴市场来利用这些机会。儘管面临挑战，但市场的动态性质呈现出巨大的突破潜力，并强调了持续创新和策略适应新兴技术趋势和医疗保健需求的重要性。

主要市场统计
基准年[2023] 44.6亿美元
预测年份 [2024] 47.9亿美元
预测年份 [2030] 73亿美元
复合年增长率（%） 7.27%

市场动态：快速发展的影像引导治疗系统市场的关键市场洞察

影像导引治疗系统市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 由于慢性病盛行率上升，老年人口不断增加
    • 改变对微创手术的偏好
    • 癌症放射治疗计划数量的增加
  • 市场限制因素
    • 影像导引治疗系统的初始成本较高
  • 市场机会
    • 影像导引治疗系统的持续技术进步
    • 增加策略联盟和投资
  • 市场挑战
    • 验证标准和设备介面标准

波特五力：驾驭影像引导治疗系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解影像导引治疗系统市场的外部影响

外部宏观环境因素在塑造影像引导治疗系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解影像导引治疗系统市场的竞争格局

影像导引治疗系统市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵影像导引治疗系统市场供应商的绩效评估

FPNV 定位矩阵是评估影像导引治疗系统市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划影像引导治疗系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对影像导引治疗系统市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告提供了涵盖关键重点领域的市场全面分析：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于慢性病盛行率上升，老年人口不断增加
      • 改变对微创手术的偏好
      • 癌症放射治疗力道加大
    • 抑制因素
      • 影像导引治疗系统的初始成本较高
    • 机会
      • 影像导引治疗系统的持续技术进步
      • 增加策略联盟和投资
    • 任务
      • 检验标准和设备介面标准
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章影像导引治疗系统市场：依产品

  • 电脑断层扫描影像
  • 介入X光检查
  • 磁振造影
  • 正子断层扫描
  • 超音波系统

第七章依修改策略分類的图像导引治疗系统市场

  • 离线
  • 在线的

第八章影像导引治疗系统市场：依应用分类

  • 胃肠病学
  • 神经外科
  • 肿瘤学
  • 整形外科

第 9 章影像导引治疗系统市场：依最终使用者分类

  • 门诊手术中心
  • 诊所
  • 医院
  • 研究/学术机构

第10章美洲影像导引治疗系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太影像导引治疗系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲影像导引治疗系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Analogic Corporation
  • Brainlab AG
  • Canon Medical Systems Corporation
  • Elekta AB
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi, Ltd.
  • KARL STORZ SE & Co. KG
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Toshiba Corporation
  • Varian Medical Systems, Inc.
Product Code: MRR-43127F7279B1

The Image-guided Therapy System Market was valued at USD 4.46 billion in 2023, expected to reach USD 4.79 billion in 2024, and is projected to grow at a CAGR of 7.27%, to USD 7.30 billion by 2030.

Image-guided therapy systems (IGTS) represent an advanced intersection of imaging and therapeutic technologies, providing precise interventions in surgical and therapeutic procedures. These systems are crucial in enabling minimally invasive surgeries, improving patient outcomes, and reducing recovery times by providing real-time imaging data during procedures. The necessity arises from the increased demand for accurate, effective, and less invasive treatments across various medical fields, including neurology, cardiology, orthopedics, and oncology. End-use extends to hospitals, clinics, and research institutions seeking to enhance their surgical capabilities. The market is poised for growth driven by the rising prevalence of chronic diseases, an aging population demanding less invasive medical procedures, and continuous technological advancements in imaging modalities such as MRI, CT scans, and ultrasound. Furthermore, artificial intelligence and machine learning applications are unlocking potential opportunities for enhanced data accuracy and procedure efficiency. Key growth factors also include increasing healthcare infrastructure investments, government incentives for advanced therapeutic technologies, and expanding R&D in precision medicine. Nevertheless, the market faces limitations such as high costs of devices, procedural complexities requiring specialized skills, and stringent regulatory environments. Ongoing challenges include cybersecurity risks associated with digitally integrated systems and interoperability issues. Opportunities for innovation exist in developing cost-effective, portable IGTS solutions and integrating advanced AI-driven analytics for predictive insights. Additionally, breakthroughs in real-time 3D imaging and augmented reality can further revolutionize surgical assistance. Businesses can capitalize on these opportunities by investing in partnerships with tech companies, enhancing R&D capabilities, and focusing on emerging markets where the demand for advanced medical technology is increasing. Despite challenges, the market's dynamic nature indicates significant potential for breakthroughs, underscoring the importance of continuous innovation and strategic adaptation to emerging technological trends and healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 4.46 billion
Estimated Year [2024] USD 4.79 billion
Forecast Year [2030] USD 7.30 billion
CAGR (%) 7.27%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Image-guided Therapy System Market

The Image-guided Therapy System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the geriatric population with rising prevalence rate of chronic conditions
    • Shifting preference for minimally invasive surgeries
    • Rising in the number of initiatives for cancer radiotherapy
  • Market Restraints
    • High initial cost associated with image-guided therapy system
  • Market Opportunities
    • Ongoing technological advancements in image-guided therapy system
    • Increasing strategic alliances and investments
  • Market Challenges
    • Validation standards and device interface standards

Porter's Five Forces: A Strategic Tool for Navigating the Image-guided Therapy System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Image-guided Therapy System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Image-guided Therapy System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Image-guided Therapy System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Image-guided Therapy System Market

A detailed market share analysis in the Image-guided Therapy System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Image-guided Therapy System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Image-guided Therapy System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Image-guided Therapy System Market

A strategic analysis of the Image-guided Therapy System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Image-guided Therapy System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Analogic Corporation, Brainlab AG, Canon Medical Systems Corporation, Elekta AB, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi, Ltd., KARL STORZ SE & Co. KG, Koninklijke Philips N.V., Medtronic PLC, Olympus Corporation, Siemens Healthineers AG, Stryker Corporation, Toshiba Corporation, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Image-guided Therapy System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Computed Tomography Imaging, Intervention X-ray, Magnetic Resonance Imaging, Positron Emission Tomography, and Ultrasound Systems.
  • Based on Correction Strategy, market is studied across Offline and On Line.
  • Based on Application, market is studied across Gastroenterology, Neurosurgery, Oncology, and Orthopedic Surgery.
  • Based on End User, market is studied across Ambulatory Surgery Centers, Clinics, Hospitals, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the geriatric population with rising prevalence rate of chronic conditions
      • 5.1.1.2. Shifting preference for minimally invasive surgeries
      • 5.1.1.3. Rising in the number of initiatives for cancer radiotherapy
    • 5.1.2. Restraints
      • 5.1.2.1. High initial cost associated with image-guided therapy system
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements in image-guided therapy system
      • 5.1.3.2. Increasing strategic alliances and investments
    • 5.1.4. Challenges
      • 5.1.4.1. Validation standards and device interface standards
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Image-guided Therapy System Market, by Product

  • 6.1. Introduction
  • 6.2. Computed Tomography Imaging
  • 6.3. Intervention X-ray
  • 6.4. Magnetic Resonance Imaging
  • 6.5. Positron Emission Tomography
  • 6.6. Ultrasound Systems

7. Image-guided Therapy System Market, by Correction Strategy

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. On Line

8. Image-guided Therapy System Market, by Application

  • 8.1. Introduction
  • 8.2. Gastroenterology
  • 8.3. Neurosurgery
  • 8.4. Oncology
  • 8.5. Orthopedic Surgery

9. Image-guided Therapy System Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Clinics
  • 9.4. Hospitals
  • 9.5. Research & Academic Institutes

10. Americas Image-guided Therapy System Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Image-guided Therapy System Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Image-guided Therapy System Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Analogic Corporation
  • 3. Brainlab AG
  • 4. Canon Medical Systems Corporation
  • 5. Elekta AB
  • 6. FUJIFILM Holdings Corporation
  • 7. GE Healthcare
  • 8. Hitachi, Ltd.
  • 9. KARL STORZ SE & Co. KG
  • 10. Koninklijke Philips N.V.
  • 11. Medtronic PLC
  • 12. Olympus Corporation
  • 13. Siemens Healthineers AG
  • 14. Stryker Corporation
  • 15. Toshiba Corporation
  • 16. Varian Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. IMAGE-GUIDED THERAPY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. IMAGE-GUIDED THERAPY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. IMAGE-GUIDED THERAPY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMAGE-GUIDED THERAPY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMAGE-GUIDED THERAPY SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY INTERVENTION X-RAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY ON LINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. IMAGE-GUIDED THERAPY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. IMAGE-GUIDED THERAPY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023